• Thursday, Dec 01, 2022
  • Last Update : 10:24 am

Momen: Russia wants to produce Sputnik V vaccine in Bangladesh

  • Published at 09:46 am April 20th, 2021
Sputnik V Vaccine
File Photo: Sputnik V gives around 92% protection against Covid-19, according to late-stage trial results published in the Lancet in February this year Reuters

As per the proposal, Russia will give the technology and Bangladeshi pharmaceutical companies would produce the Sputnik vaccine here, says the foreign minister

Russia has proposed to manufacture the Sputnik V Covid-19 vaccine in Bangladesh.

It plans to do so in collaboration with the local pharmaceuticals under a co-production arrangement, while Bangladesh is searching other sources apart from India to get the much-demanded inoculation.

“We agreed with them [Russia] in co-production [of vaccine]…though it’s not finalized yet,” Foreign Minister Dr AK Abdul Momen told BSS in a recent interview in Dhaka.

Momen said Moscow gave the proposal to manufacture the Sputnik V vaccine in Bangladesh since Russia currently does not have that much production capacity to export its vaccine to Bangladesh.

As per the proposal, Russia will give the technology and Bangladeshi pharmaceutical companies would produce the Sputnik vaccine here, he said.

“If things go well … It will be cheap and hopefully it will be better,” he added.

Recently, India has also approved the use of the Russian Sputnik V Covid-19 vaccine, as the country faces vaccine shortages amid an intensifying second wave of the deadly Covid-19 virus.

After fearing that India could run out of vaccines for its own citizens while its opposition leaders demanded an immediate moratorium on the export of vaccines, Dhaka started vigorously hunting for other sources, including China, for getting the high-in-demand vaccines.

Keeping options open

The minister said Bangladesh did not show much interest in the Chinese vaccine earlier as their vaccine was not approved by the World Health Organization (WHO).

“But, now we are keeping all options open to get vaccines,” Momen said.

However, he said, China has informed Bangladesh that they would not be able to export any vaccine before December as they have already given commitment to other countries to supply their vaccine.

Besides, he said, the World Bank (WB) recently informed Bangladesh to provide 80 million doses of vaccine under Covax by next month. “We are hopeful to get those vaccines under Covax,” he said.

Covax is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI), and THO that aims to accelerate the development and manufacture of Covid-19 vaccine, and to guarantee fair and equitable access for every country in the world.

On January 21, Bangladesh received its first-ever Covid-19 vaccine consignment while India sent 20 million doses as a gift as part of their neighborhood first policy.

Later, during the visit of Indian Prime Minister Narendra Modi here, Bangladesh also got 1.2 million doses of vaccine as a gift.

Apart from the gift, Bangladesh purchased 30 million doses of India-made vaccine under a tripartite memorandum of understanding (MoU) signed on November 5 and a subsequent agreement on December 13 among the Bangladesh government, Beximco Pharmaceuticals Ltd (BPL), and the Serum Institute of India (SII).

As per the agreement, Bangladesh is supposed to receive five million doses in each month, but after the first consignment of 5 million, Dhaka is yet to receive the second consignment of 5 million that was scheduled to arrive here by March.

“They [India] have been telling us that they would send the vaccines…they never said that they couldn’t,” Momen said, adding that Dhaka keeps confidence in Indian assurance and is hopeful to get all the 30 million doses of vaccine within the timeframe of the agreement.

Although, the minister said Dhaka feared that Indian vaccine production is not enough considering their internal demand and international commitment.

Momen said that the government has also considered engaging the private sector in importing and marketing commercially expensive vaccines like the Pfizer-BioNTech one in the Bangladesh market to meet the demand.

The government aims to vaccinate 80% of the total population free of cost to check the spreading of the deadly virus.

In Bangladesh, so far, nearly 5.7 million people have received the first dose of the vaccine while around seven million more have registered to get inoculated.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail